Last modified on 6 October 2011, at 21:15

Active surveillance

Revision as of 21:15, 6 October 2011 by Sonal.pingle (Talk | contribs)

To go back to the previous page, click here

  • Active surveillance refers to observation and regular monitoring without invasive treatment. In the context of prostate disease this usually comprises regular PSA blood tests and prostate biopsies. Active surveillance is often used when an early stage, slow-growing prostate cancer is suspected. However, watchful waiting may also be suggested when the risks of surgery, radiation therapy, or hormonal therapy outweigh the possible benefits.
  • Approximately one-third of men that choose active surveillance for early stage tumors eventually have signs of tumor progression, and they may need to begin treatment within three years.
  • Study results in 2011 suggest active surveillance is the best choice for older 'low-risk' patients. For younger men, a trial of active surveillance may not mean avoiding treatment altogether, but may reasonably allow a delay of a few years or more

Source: ncicancerbulletin & Urology-Journal



To go back to the previous page, click here